申请人:DEUTSCHES KREBSFORSCHUNGSZENTRUM
公开号:US10344067B2
公开(公告)日:2019-07-09
The present invention relates to a recombinant virus of the family Paramyxoviridae, comprising at least one expressible polynucleotide encoding an IL-12 polypeptide, wherein said IL-12 polypeptide is an IL-12 fusion polypeptide comprising a p35 subunit of an IL-12 and a p40 subunit of an IL-12; to a polynucleotide encoding the same, and to a kit comprising the same. Moreover, the present invention relates to a method for treating cancer in a subject afflicted with cancer, comprising contacting said subject with a recombinant virus of the family Paramyxoviridae of the invention, and thereby, treating cancer in a subject afflicted with cancer.
本发明涉及一种副粘病毒科重组病毒,其包含至少一种编码IL-12多肽的可表达多核苷酸,其中所述IL-12多肽是IL-12融合多肽,其包含IL-12的p35亚基和IL-12的p40亚基;本发明还涉及编码本发明的多核苷酸以及包含本发明的试剂盒。此外,本发明还涉及一种治疗癌症患者癌症的方法,包括使所述患者与本发明的副粘病毒科重组病毒接触,从而治疗癌症患者的癌症。